Equities

USANA Health Sciences Inc

USANA Health Sciences Inc

Actions
Consumer Staples Food Producers
  • Price (USD)38.10
  • Today's Change-0.32 / -0.83%
  • Shares traded18.21k
  • 1 Year change-35.93%
  • Beta0.8998
Data delayed at least 15 minutes, as of Sep 16 2024 18:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.

  • Revenue in USD (TTM)875.12m
  • Net income in USD55.08m
  • Incorporated1992
  • Employees1.80k
  • Location
    USANA Health Sciences Inc3838 W Parkway BlvdSALT LAKE CITY 84120-6336United StatesUSA
  • Phone+1 (801) 954-7100
  • Fax+1 (801) 956-9486
  • Websitehttps://www.usana.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Seneca Foods Corp1.46bn52.78m425.79m2.90k8.490.7244.420.29077.237.23203.1184.831.121.6316.04505,057.304.035.824.866.8511.9911.293.614.140.45622.580.50700.00-3.363.99588.85---0.5852--
Calavo Growers, Inc.732.77m1.37m516.60m3.06k388.232.5433.600.7050.0748-0.499241.1511.451.8418.7911.43239,153.100.56010.96670.77451.299.337.660.30470.35821.773.460.1595---18.40-2.24-33.53---6.55-12.49
Oatly Group AB (publ) - ADR793.07m-330.76m541.50m1.47k--2.22--0.6828-0.5859-0.58591.140.41030.67996.657.68512,316.50-28.38---57.34--23.47---41.74--0.5299--0.6659--8.46---6.19------
Westrock Coffee Co835.47m-48.42m622.66m1.40k--7.63--0.7453-0.5748-0.57488.994.020.88944.318.23597,188.70-4.76---6.41--17.78---5.35--0.665-0.77470.5708---0.3639--55.25------
Kuber Resources Corp3.76m1.84m636.51m16.00800.00135.75296.76169.280.0060.0060.01330.03540.8676--1.91--42.40--65.96--90.20--48.87--2.10--0.0966--43.94--60.65------
BRC Inc407.59m-7.65m703.45m630.00--47.22--1.73-0.1205-0.12056.240.07011.653.4016.20646,974.60-9.80---20.91--35.62---5.95--0.5863-1.370.5606--31.30--79.80------
B&G Foods Inc2.00bn-116.27m723.56m2.91k--0.9458--0.3617-1.54-1.5425.729.660.56592.5314.04687,045.00-3.291.13-3.661.2121.9921.87-5.812.040.48371.370.7278267.74-4.653.93-627.65---9.20-16.57
USANA Health Sciences, Inc.875.12m55.08m731.99m1.80k13.441.4310.720.83652.862.8645.4126.891.422.72--486,176.108.9316.2310.8421.7580.7781.426.298.963.44--0.000.00-7.77-4.98-8.02-12.764.86--
Herbalife Ltd5.04bn82.00m747.33m9.20k9.10--3.730.14820.8150.81549.97-10.301.882.3059.63548,010.903.0511.305.2018.7077.0178.431.636.020.7512.631.790.00-2.730.688-55.74-13.679.95--
Hain Celestial Group Inc1.74bn-75.04m748.41m2.79k--0.7937--0.431-0.8358-0.835819.3510.490.79354.6410.21623,218.30-3.31-0.1124-3.75-0.128321.9322.88-4.17-0.13631.011.820.4411---3.36-3.7735.61---15.09--
John B. Sanfilippo & Son, Inc.1.07bn60.25m1.08bn1.80k18.003.3412.701.015.165.1691.2927.802.274.6213.53592,657.3012.8114.0116.5218.6020.0720.715.656.270.774432.550.0883.846.714.01-4.158.8313.437.78
Data as of Sep 16 2024. Currency figures normalised to USANA Health Sciences Inc's reporting currency: US Dollar USD

Institutional shareholders

39.69%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20241.62m8.49%
The Vanguard Group, Inc.as of 30 Jun 20241.55m8.16%
Renaissance Technologies LLCas of 30 Jun 20241.18m6.19%
Pzena Investment Management LLCas of 30 Jun 2024976.63k5.13%
Dimensional Fund Advisors LPas of 30 Jun 2024634.62k3.33%
Pacer Advisors, Inc.as of 30 Jun 2024467.35k2.45%
SSgA Funds Management, Inc.as of 30 Jun 2024432.38k2.27%
Geode Capital Management LLCas of 30 Jun 2024284.22k1.49%
Charles Schwab Investment Management, Inc.as of 30 Jun 2024208.93k1.10%
D. E. Shaw & Co. LPas of 30 Jun 2024205.46k1.08%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.